TIME-COURSE EFFECTS OF MK-801 - THE RELATIONSHIP BETWEEN BRAIN NEUROCHEMISTRY AND BEHAVIOR

被引:27
作者
DAI, HL
GEBHARDT, K
CAREY, RJ
机构
[1] VET ADM MED CTR, RES SERV 151, SYRACUSE, NY 13210 USA
[2] SUNY HLTH SCI CTR, SYRACUSE, NY 13210 USA
[3] UNIV DUSSELDORF, W-4000 DUSSELDORF, GERMANY
关键词
MK-801; DOPAMINE; SEROTONIN; TIME COURSE; BEHAVIOR;
D O I
10.1016/0361-9230(94)00188-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Separate groups of rats were given saline or MK-801 treatments (0.3 mg/kg) and tested for locomotion activity levels for 10 min at 30, 60, and 120 min postinjection. At each postinjection time interval the MK-801 rats exhibited a marked hyperactivity that was unchanged across the three postinjection intervals. Ex vivo biochemical assays were performed to assess the neurochemical effects of MK-801 at each injection interval. In the striatum, a marked increase in dopamine metabolism was observed in the 120 injection group, but, otherwise, no other changes in striatum were detected. In contrast, a significant increase in dopamine metabolism was observed after 30 min in the medial prefrontal cortex, and this effect persisted across all postinjection intervals. At 120 min, however, the biochemical impact of the MK-801 treatment on medial prefrontal cortex broadened to include a decrease in purine metabolism and norepinephrine. Serotonin metabolism was unaffected in striatum or medial prefrontal cortex across all injection intervals, and there was no effect of MK-801 on plasma corticosterone levels.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 60 条
[1]  
BLANCHARD DC, 1992, PSYCHOPHARMACOLOGY, V108, P352
[2]  
BOROWSKY B, 1991, J PHARMACOL EXP THER, V256, P204
[3]   DIAZEPAM ANTAGONIZES EFFECTS ON DOPAMINE METABOLISM PRODUCED BY PCP RECEPTOR AGONISTS [J].
BOWERS, MB ;
MORTON, JB .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1992, 16 (02) :211-215
[4]   THE NONCOMPETITIVE NMDA-RECEPTOR ANTAGONIST MK-801 PREVENTS THE MASSIVE RELEASE OF GLUTAMATE AND ASPARTATE FROM RAT STRIATUM INDUCED BY 1-METHYL-4-PHENYLPYRIDINIUM (MPP+) [J].
CARBONI, S ;
MELIS, F ;
PANI, L ;
HADJICONSTANTINOU, M ;
ROSSETTI, ZL .
NEUROSCIENCE LETTERS, 1990, 117 (1-2) :129-133
[5]   DIFFERENTIAL TEMPORAL DYNAMICS OF SERUM AND BRAIN COCAINE - RELATIONSHIP TO BEHAVIORAL, NEUROENDOCRINE AND NEUROCHEMICAL COCAINE-INDUCED RESPONSES [J].
CAREY, RJ ;
DAMIANOPOULOS, EN ;
DEPALMA, G .
LIFE SCIENCES, 1994, 55 (22) :1711-1716
[6]   EARLY L-DOPA TREATMENT INITIALLY RETARDS BUT LATER ENHANCES DOPAMINE-RECEPTOR SUPERSENSITIVITY FOLLOWING UNILATERAL DOPAMINE DENERVATION [J].
CAREY, RJ ;
PINHEIROCARRERA, M ;
TOMAZ, C ;
HUSTON, JP .
BRAIN RESEARCH, 1994, 658 (1-2) :145-154
[7]   A SIMPLIFIED METHOD FOR THE MEASUREMENT OF CAFFEINE IN PLASMA AND BRAIN - EVIDENCE FOR A CORTICAL-SUBCORTICAL CAFFEINE CONCENTRATION DIFFERENTIAL IN BRAIN [J].
CAREY, RJ ;
DEPALMA, G .
JOURNAL OF NEUROSCIENCE METHODS, 1994, 53 (01) :19-22
[8]   THE NONCOMPETITIVE NMDA ANTAGONISTS MK-801 AND PCP, AS WELL AS THE COMPETITIVE NMDA ANTAGONIST SDZ EAA494 (D-CPPENE), INTERACT SYNERGISTICALLY WITH CLONIDINE TO PROMOTE LOCOMOTION IN MONOAMINE-DEPLETED MICE [J].
CARLSSON, M ;
SVENSSON, A .
LIFE SCIENCES, 1990, 47 (19) :1729-1736
[9]   INTERFERING WITH GLUTAMATERGIC NEUROTRANSMISSION BY MEANS OF NMDA ANTAGONIST ADMINISTRATION DISCLOSES THE LOCOMOTOR STIMULATORY POTENTIAL OF OTHER TRANSMITTER SYSTEMS [J].
CARLSSON, M ;
SVENSSON, A .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (01) :45-50
[10]  
CARLSSON M, 1991, N-S ARCH PHARMACOL, V343, P568